By Anuja Vaidya
October 19, 2023 – Using telehealth to begin opioid use disorder (OUD) treatment is linked to high retention in treatment among Medicaid beneficiaries, according to a new study.
Published in JAMA Network Open, the…
Continue Reading
By Sara Heath
October 03, 2023 – A third of the 1.5 million Medicaid enrollees with opioid use disorder in 2021 did not receive medication to treat opioid use disorder (MOUD), with searing racial health disparities…
Continue Reading
Virtual opioid use disorder treatment company Bicycle Health is partnering with supermarket chain Albertsons to allow the telehealth company’s providers to prescribe buprenorphine monthly injections for opioid use disorder that can be filled inside…
Continue Reading
Virtual opioid use disorder provider Bicycle Health announced Thursday that it is partnering with Albertsons, a supermarket and pharmacy chain, to expand access to buprenorphine treatment for opioid use disorder.
Boston-based Bicycle Health is a…
By Mark Melchionna
May 08, 2023 – Led by Sen. Edward J. Markey (D-Mass.), a group of US senators have urged the Drug Enforcement Agency (DEA) to permanently establish telehealth flexibilities in prescribing buprenorphine for opioid…
Continue Reading
After the Drug Enforcement Administration (DEA) announced Wednesday that it is temporarily extending Covid-19 flexibilities for the prescribing of controlled substances via telemedicine, several telehealth advocates came out in support of the decision.
These flexibilities…
By Sarai Rodriguez
April 28, 2023 – Although buprenorphine prescribing regulations were relaxed to increase opioid treatment access, medication rates remained unchanged between 2016 and 2022; researchers suggested that additional barriers beyond buprenorphine availability may…
Continue Reading
Patients with opioid use disorder are significantly more likely to stick with their treatment plan when offered buprenorphine via telemedicine, according to a new study in The American Journal of Drug and Alcohol Abuse.
The…
Following up on its February 27 statement opposing the U.S. Drug Enforcement Administration’s proposed permanent changes to the e-prescribing of controlled medications, the American Telemedicine Association and its ATA Action sent its final comments this week…
Continue Reading
